Already approved for progressive multiple sclerosis, ocrelizumab in a second phase 3 study demonstrates meaningful clinical ...
The lights at several intersections will now include a phase where all the lights stay red, giving pedestrians the right of way in every direction.
Get insights on the upcoming HOPE 3 phase 3 trial, key endpoints, and investment risks for CAPR. Learn what to watch in ...
A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in ...
Caregivers should understand the phases of mental health recovery so they can recognize signs, strengthen bonds, and support ...
Genmab acquires Merus for $8B, boosting cancer drug pipeline with petosemtamab. Check out what this deal means for GMAB and ...
Cryptopolitan on MSN
What’s the Best Crypto to Buy Before October Kicks In? Experts Highlight MUTM Over SOL
Ethereum (ETH) and Solana (SOL) dominate headlines, yet both continue to move within narrow ranges, leaving traders i ...
Spotify has introduced lossless audio streaming using FLAC, while Apple Music continues to offer ALAC-based lossless since ...
Legit.ng on MSN
6 Critical Points From FIFA’s Sanction Letter As South Africa Lose 3 Points in World Cup Qualifiers
South Africa have been sanctioned in the 2026 FIFA World Cup qualifiers for fielding an ineligible player during their match against Lesotho in March.
Explore the latest advancements in muscle-invasive bladder cancer treatment, including immunotherapy and novel therapies ...
Dr. Yu began by highlighting that moderately hypofractionated IMRT (MH-IMRT) has been the standard of care for prostate cancer since RTOG 0415 and other landmark studies. 1 At the time this trial was ...
The approval for plaque PsO was based on data from the PROTOSTAR trial, which evaluated guselkumab in participants aged 6 to 17 years with moderate to severe plaque PsO.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results